We report on one patient in whom segmental colic intestinal pseudo-obstruction (IPO) following the surgical treatment of a grade III necrotising enterocolitis (NEC) was responsible for a severe failure to thrive. Further intestinal resection in an already short gut was avoided by using Cisapride, a new intestinal prokinetic agent (1 mg/kg/d in 4 doses, orally), which dramatically improved the symptoms and allowed weight gain and intestinal adaptation. After 6 months, Cisapride was withdrawn. IPO did not recur after 2 years of follow-up, although proximal distention persisted.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1055/s-2008-1042601 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Risk Factors for Adverse Outcomes in Term Infants with CHD and Definitive Necrotising Enterocolitis.
Cardiol Young
January 2024
Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Objectives: To define the incidence of definitive necrotising enterocolitis in term infants with CHD and identify risk factors for morbidity/mortality.
Methods: We performed a 20-year (2000-2020) single-institution retrospective cohort study of term infants with CHD admitted to the Boston Children's Hospital cardiac ICU with necrotising enterocolitis (Bell's stage ≥ II). The primary outcome was a composite of in-hospital mortality and post-necrotising enterocolitis morbidity (need for extracorporeal membrane oxygenation, multisystem organ failure based on the paediatric sequential organ failure assessment score, and/or need for acute gastrointestinal intervention).
Predictive factors and clinical practice profile for strictures post-necrotising enterocolitis.
Medicine (Baltimore)
March 2017
Ministry of Education Key Laboratory of Child Development and Disorders, Children's Hospital, Chongqing Medical University, Chongqing Department of Neonatology, Jinan Maternity and Child Care Hospital, Shandong Province Department of Neonatology, Yongchuan Hospital, Chongqing Medical University Department of Pediatric Surgery, Sanxia Hospital, Chongqing, P.R. China.
Intestinal stricture is a severe and common complication of necrotizing enterocolitis (NEC), causing severe and prolonged morbidity. Our goal was to investigate the clinical predictors for strictures developing after NEC and evaluate the management outcome of the post-NEC strictures to better orient their medicosurgical care.A total of 188 patients diagnosed with NEC with identical treatment protocols throughout the period under study were retrospectively reviewed from 4 academic neonatal centers between from January 1, 2011, and October 31, 2016.
View Article and Find Full Text PDFThe value of contrast studies in the evaluation of bowel strictures after necrotising enterocolitis.
Pediatr Surg Int
May 2016
Department of Paediatric Surgery, Chelsea and Westminster Hospital NHS Foundation Trust London, 369 Fulham Road, London, SW109NH, UK.
Purpose: Strictures of the bowel are a frequent complication post-necrotising enterocolitis (NEC). Contrast studies are routinely performed prior to stoma closure following NEC. The aim of this study was to evaluate the ability of these studies to detect strictures and also directly compare them to operative and histological findings.
View Article and Find Full Text PDFIntestinal strictures post-necrotising enterocolitis: clinical profile and risk factors.
J Neonatal Surg
May 2015
John Hunter Children's Hospital, New Lambton Heights, NSW, Australia.
Background: Intestinal stricture is an important complication of necrotising enterocolitis (NEC). We aimed to describe clinical profile and identify the risk factors for post-NEC intestinal strictures.
Method: A retrospective study of infants with NEC over 10 year period.
Post-necrotising enterocolitis pseudo-obstruction treated with Cisapride.
Z Kinderchir
October 1990
Département de Chirurgie Pédiatrique, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Belgium.
We report on one patient in whom segmental colic intestinal pseudo-obstruction (IPO) following the surgical treatment of a grade III necrotising enterocolitis (NEC) was responsible for a severe failure to thrive. Further intestinal resection in an already short gut was avoided by using Cisapride, a new intestinal prokinetic agent (1 mg/kg/d in 4 doses, orally), which dramatically improved the symptoms and allowed weight gain and intestinal adaptation. After 6 months, Cisapride was withdrawn.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!